621. Lymphomas: Translational Molecular and Genetic: Poster III

Novel mechanistic insights for IRAK1 and IRAK4 signaling provide a framework for the development of dual IRAK1 and IRAK4 protacs for MYD88 mutated lymphomas.

Integration of longitudinal ctdna MRD and PET/CT enhances prognostic stratification in newly diagnosed diffuse large B-cell lymphoma: A prospective multicenter study

Distinct genomic landscape & response dynamics of HIV-associated lymphomas identified by integrated noninvasive host and virome profiling

Comprehensive analysis of early ctdna kinetics following first cycle of R-CHOP in LBCL patients

TP53 mutations in paired bone marrow and cell-free DNA samples of patients with Waldenstroem macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL_biowm study

Genomic characteristics of diffuse large B-cell lymphoma associated with Wiskott-Aldrich syndrome

Biomarker analysis to unravel mechanisms of resistance to glofitamab monotherapy in large B cell lymphoma

The prevalence of inborn errors of immunity (IEI)-related gene germline variants and its prognostic impact in Chinese pediatric patients with lymphoma

Gene-regulatory axes of diffuse large B-cell lymphoma subtypes

Epitranscriptomic signatures define prognosis and therapeutic vulnerabilities in large B-cell lymphoma

Phased variant circulating tumor DNA (ctDNA) tracking provides limited additional power in predicting progressive disease compared with duplex variant tracking in patients with Relapsed/Refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)

Dissecting the biology of hairy cell leukemia variant: Insights from whole exome and RNA sequencing

Deciphering tph cells as prognostic drivers of angioimmunoblastic T-cell lymphoma

An immune desert phenotype underlies therapy resistance in LBCL through distinct microenvironment-related miRNA profiles

DNMT3B functions as tumor suppressor in mantle cell lymphoma

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Spatially decoding genotype-associated epigenetic landscapes in human lymphoma FFPE tissues via epi-Patho-DBiT

Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY project